Richard E Uihlein - Net Worth and Insider Trading
Richard E Uihlein Net Worth
The estimated net worth of Richard E Uihlein is at least $9 Million dollars as of 2024-12-28. Richard E Uihlein is the Director, 10% Owner of Galectin Therapeutics Inc and owns about 7,920,901 shares of Galectin Therapeutics Inc (GALT) stock worth over $9 Million. Details can be seen in Richard E Uihlein's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Richard E Uihlein has not made any transactions after 2020-09-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Richard E Uihlein
Richard E Uihlein Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Richard E Uihlein owns 1 companies in total, including Galectin Therapeutics Inc (GALT) .
Click here to see the complete history of Richard E Uihlein’s form 4 insider trades.
Insider Ownership Summary of Richard E Uihlein
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GALT | Galectin Therapeutics Inc | 2020-09-04 | director & 10 percent owner |
Richard E Uihlein Latest Holdings Summary
Richard E Uihlein currently owns a total of 1 stock. Richard E Uihlein owns 7,920,901 shares of Galectin Therapeutics Inc (GALT) as of September 4, 2020, with a value of $9 Million.
Latest Holdings of Richard E Uihlein
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GALT | Galectin Therapeutics Inc | 2020-09-04 | 7,920,901 | 1.15 | 9,109,036 |
Holding Weightings of Richard E Uihlein
Richard E Uihlein Form 4 Trading Tracker
According to the SEC Form 4 filings, Richard E Uihlein has made a total of 1 transactions in Galectin Therapeutics Inc (GALT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Galectin Therapeutics Inc is the acquisition of 10,000 shares on September 4, 2020, which cost Richard E Uihlein around $25,500.
Insider Trading History of Richard E Uihlein
- 1
Richard E Uihlein Trading Performance
GuruFocus tracks the stock performance after each of Richard E Uihlein's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Richard E Uihlein is -11.93%. GuruFocus also compares Richard E Uihlein's trading performance to market benchmark return within the same time period. The performance of stocks bought by Richard E Uihlein within 3 months outperforms 0 times out of 7 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Richard E Uihlein's insider trading performs compared to the benchmark.
Performance of Richard E Uihlein
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.32 | | | | | |
| Relative Return to S&P 500(%) | -3.55 | | | | | |
Richard E Uihlein Ownership Network
Richard E Uihlein Owned Company Details
What does Galectin Therapeutics Inc do?
Who are the key executives at Galectin Therapeutics Inc?
Richard E Uihlein is the director & 10 percent owner of Galectin Therapeutics Inc. Other key executives at Galectin Therapeutics Inc include Chief Financial Officer Jack W Callicutt , 10 percent owner 10x Fund, L.p. , and Chief Medical Officer Pol F Boudes .
Galectin Therapeutics Inc (GALT) Insider Trades Summary
Over the past 18 months, Richard E Uihlein made no insider transaction in Galectin Therapeutics Inc (GALT). Other recent insider transactions involving Galectin Therapeutics Inc (GALT) include a net purchase of 16,867 shares made by Kary Eldred , a net purchase of 26,300 shares made by Kevin D Freeman , and a net purchase of 14,500 shares made by Zordani Richard A. Jr. .
In summary, during the past 3 months, insiders sold 109,654 shares of Galectin Therapeutics Inc (GALT) in total and bought 45,269 shares, with a net sale of 64,385 shares. During the past 18 months, 134,654 shares of Galectin Therapeutics Inc (GALT) were sold and 58,667 shares were bought by its insiders, resulting in a net sale of 75,987 shares.
Galectin Therapeutics Inc (GALT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Galectin Therapeutics Inc Insider Transactions
Richard E Uihlein Mailing Address
Above is the net worth, insider trading, and ownership report for Richard E Uihlein. You might contact Richard E Uihlein via mailing address: 12575 Uline Drive, Pleasant Prairie Wi 53158.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
